[go: up one dir, main page]

NO20070805L - Medikamentavleveringssystem. - Google Patents

Medikamentavleveringssystem.

Info

Publication number
NO20070805L
NO20070805L NO20070805A NO20070805A NO20070805L NO 20070805 L NO20070805 L NO 20070805L NO 20070805 A NO20070805 A NO 20070805A NO 20070805 A NO20070805 A NO 20070805A NO 20070805 L NO20070805 L NO 20070805L
Authority
NO
Norway
Prior art keywords
delivery system
core
drug delivery
membrane
therapeutically active
Prior art date
Application number
NO20070805A
Other languages
English (en)
Other versions
NO334931B1 (no
Inventor
Teppo Riihimaki
Original Assignee
Schering Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34932022&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20070805(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Oy filed Critical Schering Oy
Publication of NO20070805L publication Critical patent/NO20070805L/no
Publication of NO334931B1 publication Critical patent/NO334931B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Communication Control (AREA)
  • Adjustment And Processing Of Grains (AREA)
  • Vending Machines For Individual Products (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Selective Calling Equipment (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

Avleveringssystem omfattende en kjeme og en membran som omslutter kjemen. Kjemen og membranen består hovedsakelig av et elastomermateriale, og kjemen omfatter minst ett terapeutisk aktivt middel. Avleveringssystemet er kjennetegnet ved at membranen omfatter minst ett reguleringsmiddel. Oppflimelsen angår også en fremgangsmåte for å regulere fiigivelsen av minst ett terapeutisk aktivt middel fra et avleveringssystem.
NO20070805A 2004-07-13 2007-02-12 Medikamentavleveringssystem. NO334931B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04396049A EP1629844B2 (en) 2004-07-13 2004-07-13 A longterm delivery system with controlled initial burst
PCT/FI2005/000314 WO2006005794A1 (en) 2004-07-13 2005-07-05 A delivery system

Publications (2)

Publication Number Publication Date
NO20070805L true NO20070805L (no) 2007-02-12
NO334931B1 NO334931B1 (no) 2014-07-14

Family

ID=34932022

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070805A NO334931B1 (no) 2004-07-13 2007-02-12 Medikamentavleveringssystem.

Country Status (23)

Country Link
US (1) US7850986B2 (no)
EP (1) EP1629844B2 (no)
JP (1) JP4881861B2 (no)
KR (1) KR20070035032A (no)
CN (1) CN1984639A (no)
AT (1) ATE372772T1 (no)
AU (1) AU2005261682B2 (no)
BR (1) BRPI0513295A (no)
CA (1) CA2569542C (no)
DE (1) DE602004008912T3 (no)
DK (1) DK1629844T4 (no)
ES (1) ES2293193T5 (no)
IL (1) IL179846A (no)
MX (1) MX2007000433A (no)
NO (1) NO334931B1 (no)
NZ (1) NZ551823A (no)
PL (1) PL1629844T5 (no)
PT (1) PT1629844E (no)
RU (1) RU2412693C2 (no)
SI (1) SI1629844T1 (no)
UA (1) UA91337C2 (no)
WO (1) WO2006005794A1 (no)
ZA (1) ZA200610473B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2293193T5 (es) 2004-07-13 2012-06-13 Bayer Schering Pharma Oy Sistema de suministro retardado con descarga inicial controlada
US8541028B2 (en) * 2004-08-04 2013-09-24 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
US8124601B2 (en) * 2007-11-21 2012-02-28 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
JP5502751B2 (ja) 2007-12-20 2014-05-28 エボニック コーポレイション 低残留溶媒濃度を有する微粒子を調製するためのプロセス
US20100158980A1 (en) * 2008-12-18 2010-06-24 Casey Kopczynski Drug delivery devices for delivery of therapeutic agents
RU2428205C1 (ru) * 2010-04-05 2011-09-10 Государственное Образовательное Учреждение Высшего Профессионального Образования Амурская Государственная Медицинская Академия Росздрава Способ стимуляции условно-рефлекторной деятельности в модульном устройстве
RU2429017C1 (ru) * 2010-04-05 2011-09-20 Государственное Образовательное Учреждение Высшего Профессионального Образования Амурская Государственная Медицинская Академия Росздрава Антиагрегантная активация в эксперименте in vitro
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
KR20140074281A (ko) * 2011-07-20 2014-06-17 패트릭 에프. 카이저 약물 전달용 질내 장치
CN104066460B (zh) * 2012-01-18 2016-05-18 全球创新医疗保健公司 可修改的皮肤闭合性敷料
AR089765A1 (es) 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CN105310974B (zh) * 2014-08-01 2019-08-23 山东绿叶制药有限公司 罗替戈汀及其衍生物或其药用盐的植入剂

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3832252A (en) 1970-09-29 1974-08-27 T Higuchi Method of making a drug-delivery device
NZ217844A (en) 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
DE19975054I2 (de) 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
RU2088166C1 (ru) * 1993-08-10 1997-08-27 Педдер Валерий Викторович Способ контрацепции и устройство для его осуществления
CA2582666C (en) 1994-04-08 2010-05-25 Qlt Usa, Inc. Controlled release implant
US5492947A (en) * 1994-06-23 1996-02-20 Aspen Research Corporation Barrier material comprising a thermoplastic and a compatible cyclodextrin derivative
GB2290964A (en) 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
FI97947C (fi) 1994-09-27 1997-03-25 Leiras Oy Menetelmä lääkepreparaatin valmistamiseksi
GB9522403D0 (en) † 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US6416778B1 (en) * 1997-01-24 2002-07-09 Femmepharma Pharmaceutical preparations and methods for their regional administration
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
NZ330596A (en) * 1998-06-05 2001-02-23 Dec Res Intravaginal devices allowing for increased uptake of active ingredients
WO1999061062A1 (en) † 1998-05-29 1999-12-02 Massachusetts Institute Of Technology Cyclodextrin complexes
DE19830651A1 (de) * 1998-07-09 2000-01-13 Lohmann Therapie Syst Lts Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung
AU6517900A (en) 1999-08-03 2001-02-19 Smith & Nephew, Inc. Controlled release implantable devices
DE10190041D2 (de) * 2000-01-11 2002-12-05 Roland Bodmeier Implantate, Partikel
US6299894B1 (en) † 2000-05-10 2001-10-09 Leiras Oy Drug delivery device, especially for the delivery of gestodene
WO2002032433A1 (en) * 2000-10-20 2002-04-25 Leiras Oy Drug delivery system
WO2002076426A2 (en) 2001-03-27 2002-10-03 Galen (Chemicals) Limited Intravaginal drug delivery devices for the administration of an antimicrobial agent
CN1210079C (zh) 2001-04-25 2005-07-13 上海市计划生育科学研究所 阴道环制剂及其应用
AU2002313517B2 (en) 2001-08-31 2007-09-06 Bayer Schering Pharma Oy Drug delivery system
US8404272B2 (en) 2003-06-26 2013-03-26 Poly-Med, Inc. Fiber-reinforced composite rings for intravaginal controlled drug delivery
WO2005004837A1 (en) † 2003-07-10 2005-01-20 Galen (Chemicals) Limited Intravaginal drug delivery devices
MXPA06010905A (es) * 2004-03-24 2007-03-08 Organon Nv Sistema para el suministro de farmacos basados en copolimeros de polietileno y acetato de vinilo.
ES2293193T5 (es) 2004-07-13 2012-06-13 Bayer Schering Pharma Oy Sistema de suministro retardado con descarga inicial controlada

Also Published As

Publication number Publication date
IL179846A0 (en) 2007-05-15
US20080031922A1 (en) 2008-02-07
EP1629844A1 (en) 2006-03-01
EP1629844B1 (en) 2007-09-12
WO2006005794A1 (en) 2006-01-19
HK1086751A1 (en) 2006-09-29
ES2293193T3 (es) 2008-03-16
DE602004008912T3 (de) 2012-09-13
SI1629844T1 (sl) 2007-12-31
NO334931B1 (no) 2014-07-14
IL179846A (en) 2012-07-31
DK1629844T4 (da) 2012-05-29
CN1984639A (zh) 2007-06-20
EP1629844B2 (en) 2012-04-18
PL1629844T5 (pl) 2012-10-31
ZA200610473B (en) 2008-06-25
RU2006145900A (ru) 2008-06-27
JP4881861B2 (ja) 2012-02-22
PL1629844T3 (pl) 2008-02-29
NZ551823A (en) 2008-07-31
BRPI0513295A (pt) 2008-05-06
UA91337C2 (ru) 2010-07-26
AU2005261682B2 (en) 2010-02-11
MX2007000433A (es) 2007-03-07
ATE372772T1 (de) 2007-09-15
RU2412693C2 (ru) 2011-02-27
DE602004008912D1 (de) 2007-10-25
KR20070035032A (ko) 2007-03-29
AU2005261682A1 (en) 2006-01-19
CA2569542C (en) 2012-10-09
PT1629844E (pt) 2007-10-17
US7850986B2 (en) 2010-12-14
DK1629844T3 (da) 2007-10-15
DE602004008912T2 (de) 2008-06-05
CA2569542A1 (en) 2006-01-19
ES2293193T5 (es) 2012-06-13
JP2008506672A (ja) 2008-03-06

Similar Documents

Publication Publication Date Title
NO20070805L (no) Medikamentavleveringssystem.
DK1530965T3 (da) Kontrolleret frigivelsesleveringssystem til nasal applikation
BRPI0509127A (pt) agentes terapêuticos para distúrbios do ouvido interno contendo um antagonista de il-6 como ingredientes ativo
CY1108706T1 (el) Ανοσορυθμιστης
ATE495767T1 (de) Regelungsverfahren für die eluierung von therapeutischen wirkstoffen
DE60040173D1 (de) Präsenz- und sitzungsbehandlungsinformationen
CL2010000369A1 (es) Mezcla que comprende 3-bromo-n-[4-cloro-2-metil-6[(metilamino)carbonil]fenil]-1-(3-cloro-2-piridinil)-1h-pirazol-5-carboxamida y un agente para el control de pestes seleccionada entre inhibidores de colinesterasa; composicion, cebo y trampa que comprende la mezcla; metodo para controlar pestes de invertebrados con dicha mezcla.
DE60322371D1 (de) Volumensparende arzneiform zur kontrollierten freisetzung
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
DE60116256D1 (de) Zusammensetzungen zur abgabe von cortisolantagonisten
ATE471146T1 (de) Transdermale verabreichungssysteme
ATE408664T1 (de) Abgabesystem für wirkstoff
UA100850C2 (ru) Средство для борьбы с паразитами на животных
GB2446341A (en) Method and system for transdermal drug delivery
NO20071636L (no) Flytende allergivaksineformulering for oromukosal administrering
MY122838A (en) Treating allergic and inflammatory conditions
DK2004707T3 (da) Styret fordeling af aktive steder i Ziegler-Natta-katalysatorsystemer
IS8162A (is) Aðferð til að meðhöndla eða fyrirbyggja neðri þvagvegaeinkenni
ITBO20020310A1 (it) Apparato di controllo dell ' erogazione di gas medicinali , particolarmente per l ' ausilio alla respirazione
PL1979521T3 (pl) Nowy sposób impregnowania powierzchni tekstylnych
UA87291C2 (ru) Пероральное пленкообразное лекарственное средство дезоксипеганина и способ его применения
EP1693062A3 (en) Androgen receptor-dependent gene expression control
DK2062569T3 (da) Vaginalt afgivelsessystem
DK1458376T3 (da) Darifenacin til anvendelse i behandlingen af imperiös vandladningstrang fremkaldt af overaktiv urinblære
WO2007077454A3 (en) A therapeutic composition comprising an inhibitor of an hsp 90 protein

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER OY, FI

MM1K Lapsed by not paying the annual fees